P. Olgiati, P. D’Innella, P. Prosperini, E. Torre - Vol. 8, September 2002, Issue 3
Testo Immagini Bibliografia Summary Indice
Schizofrenia e diabete mellito. Il ruolo dei nuovi antipsicotici
Schizophrenia and diabetes mellitus. The role of novel antipsychotic
drugs
2 Kassanin J. The blood sugar curve in mental disease. Arch Neurol Psychiatry 1926;16:414-9.
3 Thonnard-Neumann E. Phenothiazines and diabetes in hospitalized women. Am J Psychiatry 1956;29:827-8.
4 Thonnard-Neumann E. Phenothiazines and diabetes in hospitalized women. Am J Psychiatry 1968;124:974-82.
5 Chartan FBE, Bartlett MG. The effect of chlorpromazine («Largactil») on glucose tolerance. J Ment Sci 1955;101:351-2.
6 Hiles BW. Hyperglycemia and glycosuria following chlorpromazine therapy. JAMA 1956;162:1651-2.
7 Ryal RW. Some actions of chlorpromazine. Br J Pharmacol 1956;11:339-45.
8 Arneson GA. Phenothiazine derivatives and glucose metabolism. J Neuropsychiatry 1964;5:181-5.
9 Jori A, Bernardi D, Garattini S. Chlorpromazine and glucose metabolism. Int J Neuropharmacol 1964;3:553-8.
10 Schwartz L, Munoz L. Blood sugar levels associated with chlorpromazine. Am J Psychiatry 1968;125:253-5.
11 Lindenmayer JP, Nathan AM, Smith RC. Hyperglycemia associated with the use of atypical antipsychotics. J Clin Psychiatry 2001;62:30-8.
12 Haupt DW, Newcomer JW. Hyperglycemia and antipsychotic medications. J Clin Psychiatry 2001;62:15-26.
13 Wehring H, Alexander B, Perry PJ. Diabetes Mellitus associated with clozapine therapy. Pharmacotherapy 2000;20:844-7.
14 Liebzeit KA, Markowitz JS, Caley CF. New onset diabetes and atypical antipsychotics. Eur Neuropsychopharm 2001;11:25-32.
15 Cavazzoni P, Baker RW, Kwong K. A pharmacoepidemiological study of diabetes mellitus and antipsychotic treatment in the US. Presented at the 41st annual meeting of the New Clinical Drug Evaluation Unit. May 28-31, 2001, Phoenix, Arizona, USA.
16 Gianfrancesco F, Grogg A, Mahmoud R. Association of newly reported diabetes and antipsychotics in psychosis patients: findings from a large health plan database. Presented at the 39th annual meeting of the American College of Neuropsychopharmacology. December 10-14, 2000, San Juan, Puerto Rico.
17 Lyndenmayer JP, Smith RC, Singh A. Hyperglycemia in schizophrenic patients treated with olanzapine. J Clin Psychopharmacol 2001;48:351-3.
18 Smith RC, Lyndenmayer JP, Khandat A. Hyperglycemia in schizophrenic patients treated with olanzapine and clozapine. Presented at the 154th annual meeting of the American Psychiatric Association, May 5-10, 2001, New Orleans, Louisiana, USA.
19 Newcomer JW. Anipsychotic-related change in glucose regulation. Presented at the 154th annual meeting of the American Psychiatric Association, May 5-10, 2001, New Orleans, Louisiana, USA.
20 Sernyak MJ. Association of diabetes mellitus with atypical neuroleptics. Presented at the 154th annual meeting of the American Psychiatric Association, May 5-10, 2001, New Orleans, Louisiana, USA.
21 Hägg S, Joelsson L, Mjörndal T, Spigset O, Oja G, Dahlqvist R. Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications. J Clin Psychiatry 1998;59:294-9.
22 Melkersson KI, Hulting AL, Brismar KE. Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses. J Clin Psychiatry 1999;60:783-91.
23 Henderson DC, Cagliero E, Gray C, Nasrallah RA, Hayden DL, Schoenfeld DA, et al. Clozapine, diabetes mellitus, weight gain and lipid abnormalities: a five years naturalistic study. Am J Psychiatry 2000;157:975-81.
24 Mukherjee S, Decina P, Bocola V, Saraceni F, Scapicchio PL. Diabetes mellitus in schizophrenic patients. Compr Psychiatry 1996;37:68-73.
25 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder. 4th Ed. Washington DC: American Psychiatric Press 1994.
26 First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders - Clinician Version. Firenze: OS Organizzazioni Speciali 2000 (original work published 1997, American Psychiatric Press).
27 American Diabetes Association. National Standards for Diabetes Self-Management and American Diabetes Association Review Criteria. Diabetes Care 1999;22(Suppl 1):111-4.
28 Norusis MJ. SPSS for Windows. User’s Guide. Release 5.0. Chicago, Illinois: SPSS Inc. 1993.
29 Harris ML, Flegal KM, Cowie CC. Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in US adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998;21:518-24.
30 Kenny SJ, Aubert RE, Geiss LS. Prevalence and incidence of non-insulin-dependent diabetes. In: National Institute of Diabetes and Digestive and Kidney Diseases, eds. Diabetes in America. 2nd Ed. Bethesda: NIH Publication 1995.
31 Beghi E, Monticelli ML. Diabetic polyneuropathy in the elderly. Prevalence and risk factors in two geographic areas of Italy. Acta Neurol Scand 1997;96:223-8.